The Association of Pseudohypoparathyroidism Type Ia with Chiari Malformation Type I: A Coincidence or a Common Link?
Paria KashaniMadan RoyLinda GillisOlufemi AjaniM Constantine SamaanPublished in: Case reports in medicine (2016)
A 19-month-old boy was referred for progressive weight gain. His past medical history included congenital hypothyroidism and developmental delay. Physical examination revealed characteristics of Albright Hereditary Osteodystrophy, macrocephaly, and calcinosis cutis. He had hypocalcemia, hyperphosphatemia, and elevated Parathyroid Hormone levels. Genetic testing revealed a known mutation of GNAS gene, confirming the diagnosis of Pseudohypoparathyroidism Type Ia (PHP-Ia) (c.34C>T (p.G1n12X)). He had a normal brain MRI at three months, but developmental delay prompted a repeat MRI that revealed Chiari Malformation Type I (CM-I) with hydrocephalus requiring neurosurgical intervention. This was followed by improvement in attaining developmental milestones. Recently, he was diagnosed with growth hormone deficiency. This case suggests the potential association of CM-I with PHP-Ia. Larger studies are needed to assess whether CM-I with hydrocephalus are common associations with PHP-Ia and to define potential genetic links between these conditions. We propose a low threshold in performing brain MRI on PHP-1a patients, especially those with persistent developmental delay to rule out CM-I. Early intervention may improve neurodevelopmental outcomes and prevent neurosurgical emergencies.
Keyphrases
- weight gain
- contrast enhanced
- magnetic resonance imaging
- growth hormone
- randomized controlled trial
- single cell
- diffusion weighted imaging
- end stage renal disease
- white matter
- genome wide
- birth weight
- subarachnoid hemorrhage
- multiple sclerosis
- newly diagnosed
- healthcare
- ejection fraction
- chronic kidney disease
- cerebrospinal fluid
- copy number
- mental health
- resting state
- physical activity
- computed tomography
- cerebral ischemia
- prognostic factors
- risk assessment
- magnetic resonance
- weight loss
- type diabetes
- peritoneal dialysis
- patient reported outcomes
- metabolic syndrome
- gene expression
- dna methylation